His main professional interests are interventional cardiology, acute coronary syndromes, acute ischemic stroke and antithrombotic treatments. He is the founder and leader of the "PRAGUE Study Group" - informal academic community of Czech cardiologists cooperating on the series of randomized investigator-initiated trials.